Skip to content
Deepak Nitrite logo

Deepak Nitrite

DEEPAKNTR NSE
₹1,578.40 +57.80 (+3.80%)
P/E
27.48
View as Markdown
MCP
Close 4 Nov 2026 ₹1,578.40 −154.10 −8.89% 1Y
Start ₹1,732.50

Key Fundamentals

SmallcapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
11.40%
Debt to Equity
0.28
EPS (TTM)
₹57.43
Book Value
₹474.79
Market Cap
—
P/E (TTM)
27.48
P/B
3.32
ROE
9.82%
Dividend Yield
0.49%
EBITDA
₹1,041 Cr
52W High
₹1,897.90
52W Low
₹1,280.00
Day Range
₹1,522.90 – ₹1,590.00
Volume
4,09,433

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Deepak Nitrite peer comparison
Pidilite Industries
₹1,510.2058.04₹1,54,107 Cr13.721.42%23.90%31.00%₹15,399 Cr₹2,677 Cr
Gujarat Fluorochemicals
₹4,613.3083.76₹49,073 Cr6.040.07%7.82%9.64%₹5,303 Cr₹600 Cr
Navin Fluorine International
₹8,785.0057.03₹44,060 Cr10.100.09%19.60%21.00%₹3,634 Cr₹789 Cr
Deepak Nitrite (this company)
₹1,578.4027.48₹20,919 Cr3.320.49%9.82%11.40%₹8,575 Cr₹784 Cr
Aether Industries
₹1,540.7086.90₹20,030 Cr7.880.00%9.66%11.90%₹1,231 Cr₹235 Cr
Aarti Industries
₹447.5530.57₹15,838 Cr2.590.23%7.13%6.86%₹9,010 Cr₹531 Cr
Atul
₹5,156.5019.67₹14,827 Cr2.310.59%11.50%14.90%₹6,969 Cr₹788 Cr
Median 7 companies₹1,578.4057.03₹20,919 Cr6.040.23%9.82%11.90%₹6,969 Cr₹784 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

44 Weak

Data confidence 100/100

Category scores

Quality
49
Average
Returns, margins, earnings quality 22% weight
Valuation
52
Average
Cheap vs sector & own history 24% weight
Growth
25
Poor
Sales & profit trajectory 9% weight
Financial Health
63
Good
Solvency, leverage, coverage 9% weight
Momentum
28
Poor
Trend strength, vol-adjusted 12% weight
Ownership
39
Weak
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

2
  • Company has a low return on equity of 12.8% over last 3 years.
  • Company might be capitalizing the interest cost

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish865
OscillatorsBearish261
Moving AveragesStrong Bearish604

Key readings

RSI (14)
54.73
Neutral
MACD (12,26,9)
−21.48
Bullish
SMA (50)
1,599.85
Bearish
SMA (200)
1,620.67
Bearish

As of

Analyst Rating

Based on 15 analysts
BUY73%

11 of 15 analysts rate Buy, 0 Hold, 4 Sell.

As of

BUY
11
73%
HOLD
0
0%
SELL
4
27%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+19.10%
5Y+12.59%
3Y−0.36%
1Y−4.77%
TTM+7.12%

Net profit

Net profit growth by window
10Y+24.22%
5Y−6.62%
3Y−13.52%
1Y−20.95%
TTM+29.37%

Operating cash flow

Operating cash flow growth by window
10Y+12.43%
5Y−11.66%
3Y−6.05%
1Y−13.76%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+0.20 pp
5Y−16.21 pp
3Y−3.70 pp
1Y−0.71 pp
TTM+3.35 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹1,371 Cr
Mar 2018₹1,651 Cr
Mar 2019₹2,700 Cr
Mar 2020₹4,230 Cr
Mar 2021₹4,360 Cr
Mar 2022₹6,802 Cr
Mar 2023₹7,972 Cr
Mar 2024₹7,682 Cr
Mar 2025₹8,282 Cr
Mar 2026₹7,887 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹96.00 Cr
Mar 2018₹79.00 Cr
Mar 2019₹174 Cr
Mar 2020₹611 Cr
Mar 2021₹776 Cr
Mar 2022₹1,067 Cr
Mar 2023₹852 Cr
Mar 2024₹811 Cr
Mar 2025₹697 Cr
Mar 2026₹551 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹422 Cr −34.4% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 4 Nov 2026
AI opinion · based on fundamentals
Risk medium

Deepak Nitrite Ltd trades at ₹1,578.4 as of 2026-11-04 with a market cap of ₹20,918.6 Cr and a P/E (TTM) of 27.48. The company shows a strong long-term sales CAGR of 19% over 10 years but has faced a profit contraction of -13% over the last 3 years, while TTM profit growth of 31% signals a potential recovery phase.

Bull Case 7
  • TTM profit growth has rebounded sharply to 31%, suggesting a turnaround from the 3-year compounded profit decline of -13%
  • 10-year compounded sales growth of 19% and profit growth of 24% demonstrate a strong long-term track record of scaling revenue and earnings
  • Debt-to-equity ratio stands at a conservative 0.28, indicating a relatively clean balance sheet with limited leverage risk
  • 10-year ROE averages 20%, reflecting historically efficient capital allocation despite the recent dip
  • 5-year compounded sales growth of 13% shows the top line has continued expanding even through a challenging period for profitability
  • The stock is trading at ₹1,578.4, roughly 16.8% below its 52-week high of ₹1,897.9, which may reflect some correction of prior overvaluation
  • TTM sales growth of 7% indicates the revenue trajectory remains positive on a trailing basis
Bear Case 8
  • 3-year compounded profit growth is -13%, indicating a sustained period of earnings deterioration
  • ROE has declined from a 10-year average of 20% to 10% last year and stands at 9.38% as of 2026-11-04, signalling weakening return generation
  • 3-year ROE of only 12.8% is flagged as low, and the current ROE of 9.38% represents further deterioration from that average
  • The company may be capitalizing interest costs, which could overstate reported profitability and asset values
  • The stock has delivered a negative 1-year return of -16% and a 3-year CAGR of -10%, reflecting sustained underperformance
  • At a P/E of 27.48 and P/B of 3.32, the valuation appears elevated relative to the current single-digit ROE of 9.38% and ROCE of 10.85%
  • 5-year compounded profit growth is -7%, showing that profitability erosion has persisted over a medium-term horizon as well
  • Dividend yield of 0.49% offers minimal income cushion for investors during periods of capital depreciation

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

9h ago

TL;DR: Deepak Nitrite delivered a standout Q2 FY27 with profit tripling, EBITDA up 207%, and its Phenolics segment posting record results that already surpass prior full-year peaks in just six months. The Dahej facility going live and polycarbonate resin plans add medium-term growth visibility. Key risks include a 10.77% YTD stock decline, sequential margin compression, and reliance on import disruptions that may normalize. If Phenolics tailwinds sustain and new capacity ramps, the earnings trajectory could remain strong, but normalization of trade flows is worth monitoring.

Headwinds 3
  • Stock down 10.77% year-to-date Oct 29

    Despite strong Q2 results, shares remain under pressure with a 10.77% YTD decline, suggesting broader market or sector headwinds persisting through the year.

  • Sequential gross margin decline Oct 29

    Gross margin declined 200 basis points sequentially even as it improved 730 bps YoY to 34.8%, indicating some near-term pricing or cost pressure quarter-over-quarter.

  • Volatile global operating environment Oct 29

    The company flagged geopolitical tensions, disrupted trade flows, feedstock constraints and elevated logistics costs as ongoing challenges in its operating environment.

Positives 6
  • Q2 profit triples to ₹398 crore Oct 29

    Consolidated net profit more than tripled to ₹398 crore from ₹118.7 crore YoY, while revenue surged 61.7% to ₹3,076 crore in Q2 FY27.

  • EBITDA jumps 207%, margin doubles Oct 29

    EBITDA surged 207% to ₹627 crore with margin nearly doubling to 20.4% from 10.7% YoY, reflecting significant operational leverage and cost management.

  • Phenolics delivers best-ever quarter Oct 29

    Phenolics revenue rose 72% YoY to ₹2,291 crore with EBIT surging 256% to ₹515 crore. H1 FY27 EBIT of ₹933 crore already surpassed the previous full-year peak of ₹867 crore in FY22.

Neutral 1
  • Import disruptions aiding domestic play Oct 29

    Strong Phenolics performance was partly driven by disruptions in imports, elevated freight costs and tighter domestic availability, which are favorable but externally driven and potentially temporary.

Quarterly Results

₹ Cr
DEEPAKNTR quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
1,768
1,778
2,009
2,126
2,167
2,032
1,903
2,180
1,890
1,902
1,975
2,120
2,578
3,076
Expenses
1,559
1,476
1,705
1,825
1,858
1,734
1,735
1,863
1,700
1,698
1,764
1,744
2,037
2,450
Operating Profit
210
302
305
301
309
298
169
317
190
204
211
376
540
627
OPM %
12%
17%
15%
14%
14%
15%
9%
15%
10%
11%
11%
18%
21%
20%
Other Income
32
17
14
99
19
21
21
23
25
20
−4
7
14
16
Interest
2
3
3
4
6
6
6
9
8
8
11
19
23
29
Depreciation
38
39
42
46
47
48
48
51
51
53
58
63
64
71
PBT
202
277
274
349
275
264
135
279
155
163
138
301
468
543
Tax %
26%
26%
26%
27%
26%
26%
27%
27%
27%
27%
28%
27%
26%
27%
Net Profit
150
205
202
254
203
194
98
202
112
119
100
220
345
398
EPS (₹)
10.99
15.04
14.81
18.61
14.85
14.24
7.19
14.84
8.23
8.7
7.32
16.11
25.3
—

Sep 2026: from the results filed on 29 Oct 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
DEEPAKNTR profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1,327
1,373
1,371
1,651
2,700
4,230
4,360
6,802
7,972
7,682
8,282
7,887
8,575
Expenses
1,187
1,204
1,231
1,447
2,278
3,194
3,108
5,196
6,680
6,555
7,187
6,900
7,243
Operating Profit
140
169
139
204
421
1,035
1,252
1,607
1,292
1,127
1,095
987
1,331
OPM %
11%
12%
10%
12%
16%
24%
29%
24%
16%
15%
13%
13%
16%
Other Income
1
0
80
7
11
29
20
42
46
156
84
44
36
Interest
38
40
37
47
87
118
77
36
27
15
31
49
61
Depreciation
36
40
48
53
78
140
153
178
166
166
195
225
237
PBT
67
89
135
111
268
806
1,042
1,434
1,146
1,102
953
757
1,070
Tax %
21%
29%
28%
29%
35%
24%
26%
26%
26%
26%
27%
27%
—
Net Profit
53
63
96
79
174
611
776
1,067
852
811
697
551
783
EPS (₹)
5.06
5.39
7.37
5.79
12.73
44.8
56.88
78.2
62.47
59.45
51.12
40.36
57.43
Div. Payout %
20%
22%
16%
22%
16%
10%
10%
9%
12%
13%
15%
19%
—

Balance Sheet

₹ Cr
DEEPAKNTR balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
21
23
26
27
27
27
27
27
27
27
27
27
Reserves
325
450
689
895
1,044
1,545
2,319
3,311
4,063
4,769
5,361
5,810
Borrowings
545
529
724
987
1,187
1,107
590
315
73
286
1,267
1,638
Other Liabilities
235
295
350
684
677
538
630
779
967
1,012
1,053
1,180
Total Liabilities
1,125
1,296
1,789
2,592
2,935
3,217
3,567
4,432
5,129
6,095
7,708
8,654
Fixed Assets
549
594
586
588
1,716
1,832
1,864
1,963
1,942
2,293
2,457
3,270
CWIP
44
36
349
955
34
172
220
122
301
774
1,649
1,828
Investments
3
87
118
32
2
2
189
439
379
122
511
213
Other Assets
530
580
736
1,018
1,183
1,210
1,293
1,908
2,508
2,907
3,091
3,343
Total Assets
1,125
1,296
1,789
2,592
2,935
3,217
3,567
4,432
5,129
6,095
7,708
8,654

Cash Flow

₹ Cr
DEEPAKNTR cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
108
167
49
183
60
765
1,002
824
650
874
625
539
Investing
−89
−169
−353
−525
−163
−428
−396
−424
−276
−717
−1,489
−669
Financing
−22
4
305
345
96
−338
−599
−386
−359
44
806
193
Net Cash Flow
−3
2
1
4
−6
−1
7
14
15
200
−59
64
Free Cash Flow
18
81
−192
−438
−194
349
788
638
290
110
−494
−658
CFO/EBITDA
87
110
47
103
28
93
99
73
70
101
77
74

Ratios

DEEPAKNTR financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
86
83
96
91
78
53
63
61
60
62
56
70
Inventory Days
47
54
75
118
94
63
64
53
62
54
59
57
Days Payable
48
59
95
176
106
57
72
46
46
38
33
35
Cash Conversion Cycle
85
79
76
32
66
59
56
67
76
77
82
92
Working Capital Days
−3
−28
−49
−29
35
33
57
57
70
70
64
61
ROCE %
—
14%
8%
10%
17%
38%
40%
44%
30%
22%
16%
11%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Deepak Nitrite insights

63 extracted metrics across FY12–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 49.39%
  • DIIs 22.50%
  • Public 18.72%
  • FIIs 6.40%
  • Others 2.99%

No promoter shares pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Deepak Nitrite

What does Deepak Nitrite Ltd do?
Incorporated in 1970, Deepak Nitrite Ltd manufactures Basic Intermediates, Fine & Speciality Chemicals, Performance Products, and Phenolics
Where is Deepak Nitrite Ltd (DEEPAKNTR) listed?
Deepak Nitrite Ltd trades as DEEPAKNTR on the NSE and under code 506401 on the BSE.
Which sector does Deepak Nitrite Ltd belong to?
Deepak Nitrite Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the PE ratio of Deepak Nitrite Ltd?
Deepak Nitrite Ltd trades at a PE ratio of 27.48 as of 4 Nov 2026, on earnings per share of ₹57.43, against a book value of ₹474.79 per share.
What is the 52-week high and low of Deepak Nitrite Ltd?
Over the last 52 weeks Deepak Nitrite Ltd has traded between ₹1,280 and ₹1,897.9 as of 4 Nov 2026.
Does Deepak Nitrite Ltd pay dividends?
Deepak Nitrite Ltd has a dividend yield of 0.49%.
What is the Return on Equity (ROE) of Deepak Nitrite Ltd?
Deepak Nitrite Ltd reported a return on equity of 9.82%. Its debt-to-equity ratio is 0.28.

Company Information

Incorporated in 1970, Deepak Nitrite Ltd manufactures Basic Intermediates, Fine & Speciality Chemicals, Performance Products, and Phenolics

Website godeepak.com
CEO Mr. Deepak Chimanlal Mehta B.Sc.
Employees 1,757
Listed 29 Sep 2010
Face Value ₹2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DEEPAKNTR.md for Deepak Nitrite Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month